Key result
ACE inhibition with ramipril significantly attenuated left ventricular dysfunction after myocardial infarction in both kininogen-deficient and control rats compared to untreated animals.
Why the study?
Does ramipril improve left ventricular function after myocardial infarction in kininogen-deficient rats?
Does ramipril improve left ventricular function after myocardial infarction in kininogen-deficient rats?
ACE inhibition with ramipril improves left ventricular function after myocardial infarction even in the presence of kininogen deficiency.
Answers are grounded in this paper and cite their sources.
Ramipril attenuates post-MI LV dysfunction despite kininogen deficiency; leaves open kinin-independent mechanisms in humans.
Bradykinin (BK) coronary outflow and left ventricular (LV) performance of kininogen-deficient Brown Norway Katholiek (BNK) rats and Brown Norway Hannover (BNH) controls were investigated. We analyzed whether the angiotensin-converting enzyme (ACE) inhibitor ramipril is able to attenuate LV dysfunction after induction of myocardial infarction (MI) in this animal model. Ex vivo, the basal BK content in the coronary outflow of buffer-perfused, isolated hearts was measured by specific radioimmunoassay. In vivo, left ventricular pressure (LVP), the maximal rate of LVP increase, LV end-diastolic pressure, the maximal rate of LVP decrease and heart rate were determined using a tip catheter 3 weeks after induction of MI. Compared to BNK rats, basal BK outflow was increased 30-fold in controls (p<0.01). In vivo, we found no significant differences between sham-ligated BNK and BNH rats in basal LV function. After MI, the impairment of LV function was significantly worse in BNK rats when compared to BNH rats. ACE inhibition significantly attenuated this LV dysfunction in both groups, when compared to untreated animals. Reduced basal BK level resulting from kininogen deficiency has no effect on basal LV function, but remains to be a risk factor for the ischemic heart. However, ACE inhibition is sufficient to improve LV function despite kininogen deficiency.
No takes yet. Share an insight, caveat, or question.
Koch et al. (2008) studied Myocardial infarction. Ramipril vs. Untreated animals was evaluated on Left ventricular function (LVP, maximal rate of LVP increase, LV end-diastolic pressure, maximal rate of LVP decrease, heart rate). ACE inhibition with ramipril significantly attenuated left ventricular dysfunction after myocardial infarction in both kininogen-deficient and control rats compared to untreated animals.
Synapse has enriched 10 related papers. Consider them for comparative context: